REGULATION OF PROMER OF TGF-β/SMAD-TARGET GENE FOR ATTENUATION OF RENAL FIBROSIS
REGULATION OF PROMER OF TGF-β/SMAD-TARGET GENE FOR ATTENUATION OF RENAL FIBROSIS
批准号:
13671132
负责人:
TAMAKI Kiyoshi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
TGF-β/Smad-target gene such as plasminogen activator inhibitor has Smad-binding element (SEE) in its promoter region. We generated artificial plasmid consisted of luciferase gene with SBE (SBE-Lux) in its promoter region. Using this plasmid, we have done experiments as follows. Cultured mesangial cells or smooth muscles cells was transfected with the plasmid and the cultured cells were treated with TGF-β or the substances, which are shown to induce the production of TGF-β. TGF-β increased the activity of SBE-Lux in dose-dependent manner. Angiotension II and Advanced glycation end product (AGE) also stimulated SBE-Lux activity. The activity was blocked by the presence of neutralizing anti-TGF-β antibody.Next, we generated artificial plasmid consisted of GFP (green fluorescence product) gene with SBE (SBE-GFP) in its promoter region. The cells transfected with the construct showed TGF-β-induced green color in its cytoplasma. Thus, the cell showing green fluolorescence was considered as TGF-β-target-cells. However, the cultured cells, which were transfected with the construct and treated with Angiotension II or AGE, have not shown green color enough to be identified. In addition, the tissues, which were transfectected with SBE-GFP, have not shown the green color induced by sclerotic damage. High concentration of TGF-β more than 10^<-2>ng/ml is necessary to induce the green fluolorescence in the transfected cells. Such high concentration of TGF-β was not considered to exist in the physiological or pathological condition. Thus, more sensitive artificial promoter is necessary to detect TGF-β activity.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K.Tamaki et al.: "Role of TGF-β in the progression of renal fibrosis"Contribution to Nephrology. 139. 44-65 (2003)
K. Tamaki 等人:“TGF-β 在肾纤维化进展中的作用”肾病学贡献 139. 44-65 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamai O, Tamaki K,, Okuda S et al: "Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis."Kidney Int.. 59. 471-480 (2001)
Tamai O、Tamaki K、Okuda S 等人:“系膜细胞中的小窝和小窝蛋白在系膜增殖性肾小球肾炎中的表达。”Kidney Int.. 59. 471-480 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamaki K, Okuda S: "Role of TGF-β in the progression of renal fibrosis"Contribution to Nephrology. 139. 44-65 (2003)
Tamaki K、Okuda S:“TGF-β 在肾纤维化进展中的作用”肾病学贡献 139. 44-65 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haramaki R, Tamaki K, et al.: "Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy"Am J Kidney Dis.. 38(6). 1191-1198 (2001)
Haramaki R、Tamaki K 等人:“IgA 肾病中的类固醇疗法和尿转化生长因子-β1”Am J Kidney Dis. 38(6)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamaki K, et al.: "Chinese herbs nephropathy : a variant form in Japan"Intern Med.. 40(4). 267-268 (2001)
Tamaki K等人:“中药肾病:日本的一种变体”Intern Med.. 40(4)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Proteomic approach to protein involving diabetic nephropathy
-
批准号:15590870
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:TAMAKI Kiyoshi
-
依托单位:
REGULATION OF TGF-β AND ITS SIGNAL MOLECULE, SMAD, FOR ATTENUATION OF GLOEMRULAR DISEASE.
-
批准号:11671063
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TAMAKI Kiyoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
-
批准号:ZCLQN26H2604
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王言
-
依托单位:
LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
-
批准号:2026JJ82108
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭亮
-
依托单位:
基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究
-
批准号:JCZRLH202601800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
独活寄生汤靶向调控TGF-β1/Smad信号通路介导间充质干细胞成软骨分化治疗KOA的作用机制研究
-
批准号:2026JJ80282
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段建辉
-
依托单位:
黄精多糖通过TGF-β/SMAD信号通路抑制成纤维细胞活化治疗肺纤维化的机制研究与转化探索
-
批准号:JCZRLH202602010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
丁酸通过抑制HDAT6/TGF-β/Smad3介导的M2巨噬细胞极化改善慢性肾病肾纤维化
-
批准号:2026JJ82193
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖洁
-
依托单位:
基于TGF-β/Smad通路介导的细胞外基质重塑探讨腹主动脉瘤管壁异质性与力学失稳耦合机制
-
批准号:JCZRLH202600210
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于TGF-β/Smad信号通路探究环泊酚抑制结直肠癌的作用机制.
-
批准号:JCZRLH202601563
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
益气解毒颗粒通过TGF-β1/Smad3信号通路调控巨噬细胞-肌成纤维细胞转化抑制鼻咽癌转移的机制研究
-
批准号:2026JJ81078
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:范婧莹
-
依托单位:
补骨脂素与丹参酮IIA协同激活TGF-β1/Smad通路赋能ADSCs延缓椎间盘退变的机制研究
-
批准号:2026JJ60633
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段嘉豪
-
依托单位: